# FDA Inspection 1009605 - Taizhou Xianju Pharmaceutical Co. Ltd. - March 31, 2017

Source: https://www.keypedia.com/records/fda_inspections/taizhou-xianju-pharmaceutical-co-ltd/c928eb35-fe18-41ef-b120-6c5e93656bb3
Source feed: FDA_Inspections

> FDA Inspection 1009605 for Taizhou Xianju Pharmaceutical Co. Ltd. on March 31, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1009605
- Company Name: Taizhou Xianju Pharmaceutical Co. Ltd.
- Inspection Date: 2017-03-31
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1256835 - 2024-11-15](https://www.keypedia.com/records/fda_inspections/taizhou-xianju-pharmaceutical-co-ltd/21e5bb94-3e39-43e0-a1fa-4b5538d0a135)
- [FDA Inspection 1256835 - 2024-11-15](https://www.keypedia.com/records/fda_inspections/taizhou-xianju-pharmaceutical-co-ltd/4d0a9743-67dd-48f3-ad1b-78aa21302e07)

Company: https://www.keypedia.com/companies/taizhou-xianju-pharmaceutical-co-ltd/4b333061-9eb4-463f-9489-f78b16b0014d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c